Who owns Nymox Pharmaceutical Corporation?

Key details on Nymox Pharmaceutical Corporation (Ticker: NYMX)

Who owns Nymox Pharmaceutical Corporation?

Is NYMX a good stock to own? Find out who bought Nymox Pharmaceutical Corporation, who sold Nymox Pharmaceutical Corporation (NYMX) stock, and who holds a large position in Nymox Pharmaceutical Corporation.

Fund Name Number of Shares Share Valuation As Of
STATE STREET CORPORATION 300825 $2.42M March 31, 2012
SUSQUEHANNA INTERNATIONAL 137092 $748522 March 31, 2014
Canada Pension Plan Investment Board 120913 $660184 March 31, 2014
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 103400 $849948 Dec. 31, 2011
TIAA-CREF Investment Management 81563 $655766 March 31, 2012
WMS Partners 63350 $345891 March 31, 2014
Deutsche Bank Aktiengesellschaft 49422 $327173 Sept. 30, 2013
Fortaleza Asset Management 45090 $310219 Sept. 30, 2012
CITADEL ADVISORS 39506 $215702 March 31, 2014
Marathon Capital Management 39100 $213095 March 31, 2014
Soros Fund Management 38400 $251136 June 30, 2012
CIBC World Markets 31372 $190114 Dec. 31, 2013
ALLIANCEBERNSTEIN 30400 $244112 March 31, 2012
Eidelman Virant Capital 26796 $132908 June 30, 2014
Renaissance Technologies 26506 $144987 March 31, 2014
Charles Schwab Investment Management 26000 $215020 March 31, 2012
GOFEN & GLOSSBERG LLC /IL/ 25000 $124000 June 30, 2014
Wells Fargo & Company 24000 $131040 March 31, 2014
KCG Holdings 23325 $139950 Dec. 31, 2013
DF DENT & CO 22500 $110925 June 30, 2014
Oxford Asset Management 22203 $113901 June 30, 2013
Vanguard 21996 $177287 March 31, 2012
ING Investment Management Co Address: 10 State House Square 21000 $169050 March 31, 2012
Teachers Advisors 20265 $162930 March 31, 2012
CalPERS 20200 $109080 March 31, 2014
Croft-Leominster 20000 $109000 March 31, 2014
Nomura Holdings 19751 $109025 March 31, 2014
Scotia Capital 18393 $100057 March 31, 2014
RHUMBLINE ADVISERS 16583 $132995 March 31, 2012
Metropolitan Life Insurance Company 15898 $127978 March 31, 2012
MORGAN STANLEY 15614 $86033 March 31, 2014
GSA Capital Partners 15479 $93957 Dec. 31, 2013
GROUP ONE TRADING 15417 $94043 Dec. 31, 2013
Manulife Asset Management 14902 $119812 March 31, 2012
GOLDMAN SACHS 14580 $79023 March 31, 2013

Who sold Nymox Pharmaceutical Corporation?

Fund Name Date Sold Number of Shares Sold Share Valuation
UBS AG Sept. 30, 2011 15517 $126929
Credit Suisse AG June 30, 2011 17291 $144034
Macquarie June 30, 2011 16108 $134985
Camden Partners Holdings March 31, 2011 23600 $185968
Bank of America Corporation March 31, 2011 20252 $159990
J P MORGAN CHASE & CO Dec. 31, 2010 27362 $193175
Technical Financial Services Dec. 31, 2010 24288 $170987
OHIO PERS Dec. 31, 2010 18202 $127960